Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, PoC Analyzers), Application (UTI, Diabetes, Pregnancy), End User (Hospital, Labs, Homecare) & Test Type - Global Forecast to 2024

尿検査の世界市場予測(~2024年)

◆タイトル:Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, PoC Analyzers), Application (UTI, Diabetes, Pregnancy), End User (Hospital, Labs, Homecare) & Test Type - Global Forecast to 2024
◆商品コード:MD-3259
◆調査・発行会社:MarketsandMarkets
◆発行日:2019年3月29日
◆ページ数:147
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

尿検査の世界市場は、2019年の32億米ドルから2024年には46億米ドルに達し、この期間中7.6%の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、腎疾患や尿路感染症の世界的な蔓延、沈査分析の自動化への移行、ポイントオブケア尿検査の採用の増加などが考えられます。尿検査および新興国向けの統合システムは、市場プレイヤーに幅広い成長機会を提供すると期待されています。当調査レポートでは、尿検査の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別(ディップスティック、妊娠検査キット、試薬、消耗品、自動・半自動分析装置、PoC検査装置)分析、用途別(UTI、糖尿病、妊娠)分析、エンドユーザー別(病院、検査室、在宅医療)分析、検査の種類別分析、尿検査の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“Urinalysis market to register a CAGR of 7.6% from 2019 to 2024”The global urinalysis market is projected to reach USD 4.6 billion by 2024 from USD 3.2 billion in 2019, at a CAGR of 7.6% from 2019 to 2024. The growth of the market is largely driven by factors such as the growing global prevalence of kidney diseases and urinary tract infections, the shift towards automation in sediment analysis, and the increasing adoption of point-of-care urinalysis. Integrated systems for urinalysis and the emerging economies are expected to provide a wide range of growth opportunities for players in the market.

“Consumables accounted for a significant share of the market in 2019”
By product, the urinalysis market is segmented into consumables and instruments. The consumables segment includes pregnancy and fertility kits, dipsticks, reagents, and disposables, while the instruments segment includes automated urine analyzers, semi-automated urine analyzers, and point-of-care urine analyzers. The consumables segment dominated the market and is the fastest growing segment due to rising incidence of urinary tract infections and kidney diseases which creates the demand for regular urine checkups.

“Pregnancy and fertility tests segment accounted for the largest share of the urinalysis market in 2019”
The urinalysis market, by test type, is segmented into biochemical urinalysis, sediment urinalysis, and pregnancy & fertility tests. The pregnancy & fertility tests segment is estimated to account for the largest share of the urinalysis market in 2019 while the sediment urinalysis segment is estimated to witness the highest growth rate during the forecast period. The rising incidence of UTIs and kidney diseases and the shift towards automation are the major factors driving the growth of this segment.

“Disease screening segment accounted for the largest share of the urinalysis market in 2019”
On the basis of application, the urinalysis market is segmented into disease screening and pregnancy & fertility. In the disease screening segment, UTIs have the largest market share. Urine analysis has become a part of the general check-up in many countries and is used as a preliminary technique for screening for UTIs and other kidney diseases. This is followed by high throughput technique for diagnosing the diseases.

“Hospitals and clinics segment accounted for the largest share of the urinalysis market in 2019”
On the basis of end user, the urinalysis market is segmented into hospitals & clinics, diagnostic laboratories, home care settings, and research laboratories & institutes. Of all these end-user segments, hospitals & clinics accounted for the largest share of the urinalysis market in 2019. The large share of this segment can be attributed to factors such as the rapidly growing aging population, the increasing global incidence of kidney diseases and UTIs, increase in reimbursements for clinical tests performed in hospitals among others.

“North America dominated the urinalysis market in 2019”
North America, which includes the US, & Canada, accounted for the largest share of the urinalysis market. The growth in this market is primarily driven by the increasing prevalence of UTIs and kidney diseases, rising geriatric population, favorable government initiatives, increasing healthcare expenditure, improved healthcare infrastructure, and availability of technologically advanced urinalysis instruments in the region.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (20%) , Tier 2 (45%), and Tier 3 (35%)
• By Designation: C-level (30%), Director-level (20%), and Others (50%)
• By Region: North America (35%), Europe (24%), Asia (25%), and RoW (16%)

The major players operating in this market are Seimens Healthineers (Germany), Roche Diagnostics (Switzerland), Cardinal Health (US), Arkray Inc (Japan), Sysmex Corporation (Japan), Alere Inc. (US), Beckman Coulter (US), Bio-Rad Laboratories (US), 77 Elektronika Kft (Hungary), and DIRUI (China), ACON Laboratories (US), Quidel Corporation (US) and URIT Medical Electronic Ltd. (China). Product launches, partnerships and acquisitions are the key growth strategies followed by most players in this market.

Research Coverage
This report studies the urinalysis market based on product, test type, application end user and region. The report also analyzes factors (such as drivers, restraints and opportunities) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total urinalysis market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on urinalysis offered by the top 13 players in the urinalysis market. The report analyzes the urinalysis market by type, application, and region

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various urinalysis across key geographic regions.

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the urinalysis market

• Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the urinalysis market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.2.1 MARKETS COVERED 17
1.2.2 YEARS CONSIDERED FOR THE STUDY 18
1.3 CURRENCY 18
1.4 LIMITATIONS 18
1.5 STAKEHOLDERS 19
2 RESEARCH METHODOLOGY 20
2.1 SECONDARY DATA 21
2.1.1 KEY DATA FROM SECONDARY SOURCES 21
2.2 PRIMARY DATA 22
2.2.1 KEY DATA FROM PRIMARY SOURCES 23
2.3 MARKET SIZE ESTIMATION 24
2.3.1 BOTTOM-UP APPROACH 24
2.3.2 TOP-DOWN APPROACH 25
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 26
2.5 ASSUMPTIONS FOR THE STUDY 27
3 EXECUTIVE SUMMARY 28
4 PREMIUM INSIGHTS 32
4.1 URINALYSIS: MARKET OVERVIEW 32
4.2 NORTH AMERICA: URINALYSIS MARKET, BY PRODUCT (2019) 33
4.3 GEOGRAPHICAL SNAPSHOT OF THE URINALYSIS MARKET 34
5 MARKET OVERVIEW 35
5.1 INTRODUCTION 35
5.2 MARKET DYNAMICS 35
5.2.1 DRIVERS 36
5.2.1.1 Growing global prevalence of kidney diseases and urinary tract infections 36
5.2.1.2 Shift towards automation in sediment analysis 37
5.2.1.3 Increasing adoption of point-of-care urinalysis 37
5.2.2 OPPORTUNITIES 37
5.2.2.1 Integrated systems for urinalysis 37
5.2.2.2 Emerging economies 37

5.2.3 CHALLENGES 38
5.2.3.1 High cost of automated analyzers affecting market penetration in emerging economies 38
6 URINALYSIS MARKET, BY PRODUCT 39
6.1 INTRODUCTION 40
6.2 CONSUMABLES 41
6.2.1 PREGNANCY & FERTILITY KITS 42
6.2.1.1 Need for rapid pregnancy testing to drive market growth 42
6.2.2 DIPSTICKS 43
6.2.2.1 Dipsticks are used regularly due to their low cost and ease of use 43
6.2.3 DISPOSABLES 44
6.2.3.1 Wide usage of urine collection cups will drive the market for disposables 44
6.2.4 REAGENTS 44
6.2.4.1 Increasing use of controls and calibrators to drive market growth 44
6.3 INSTRUMENTS 45
6.3.1 AUTOMATED URINE ANALYZERS 46
6.3.1.1 Biochemical urine analyzers 47
6.3.1.1.1 Increasing incidence of kidney diseases and urinary tract infections will increase the demand for automated biochemical analyzers 47
6.3.1.2 Sediment urine analyzers 48
6.3.1.2.1 Microscopy analyzers 49
6.3.1.2.1.1 Increased adoption of automated microscopy analyzers to drive market growth 49
6.3.1.2.2 Flow cytometry analyzers 49
6.3.1.2.2.1 Accuracy and sensitivity of flow cytometry technique to drive the adoption of these analyzers 49
6.3.1.3 Integrated urine analyzers 50
6.3.1.3.1 Higher workload in hospitals and laboratories to drive the adoption of integrated systems 50
6.3.2 SEMI-AUTOMATED URINE ANALYZERS 51
6.3.2.1 Semi-automated urine analyzers are used extensively due to their low cost and ease of use 51
6.3.3 POINT-OF-CARE URINE ANALYZERS 51
6.3.3.1 Need for rapid testing to drive the demand for PoC devices 51

7 URINALYSIS MARKET, BY TEST TYPE 53
7.1 INTRODUCTION 54
7.2 PREGNANCY & FERTILITY TESTS 55
7.2.1 RISING INCIDENCE OF ACCIDENTAL PREGNANCIES TO DRIVE THE GROWTH OF THIS SEGMENT 55
7.3 BIOCHEMICAL URINALYSIS 55
7.3.1 LABORATORY TESTS 56
7.3.1.1 Increasing incidence of urinary tract infections and kidney diseases to drive the growth of this segment 56
7.3.2 POINT-OF-CARE TESTS 57
7.3.2.1 Ease and convenience of poc testing to drive the growth of this segment during the forecast period 57
7.4 SEDIMENT URINALYSIS 58
7.4.1 INCREASING ADOPTION OF AUTOMATED ANALYZERS TO DRIVE THE GROWTH OF THIS SEGMENT 58
8 URINALYSIS MARKET, BY APPLICATION 59
8.1 INTRODUCTION 60
8.2 DISEASE SCREENING 61
8.2.1 URINARY TRACT INFECTIONS 62
8.2.1.1 Increasing prevalence of UTIs to drive growth in the urinalysis market for disease screening 62
8.2.2 KIDNEY DISEASES 62
8.2.2.1 Rapidly growing global geriatric population and the subsequent increase in the prevalence of kidney diseases to drive market growth 62
8.2.3 DIABETES 63
8.2.3.1 Development of advanced analytical tools for diabetes will drive market growth 63
8.2.4 LIVER DISEASES 64
8.2.4.1 High prevalence of liver diseases will increase the demand for urinalysis 64
8.2.5 OTHER DISEASE SCREENING APPLICATIONS 65
8.3 PREGNANCY & FERTILITY 65
8.3.1 NEED FOR EARLY DETECTION OF PREGNANCY & FERTILITY TO DRIVE GROWTH IN THE URINALYSIS MARKET 65
9 URINALYSIS MARKET, BY END USER 67
9.1 INTRODUCTION 68
9.2 HOSPITALS & CLINICS 70
9.2.1 INCREASE IN HOSPITALIZATIONS FOR URINARY DISEASES TO DRIVE GROWTH IN THIS END-USER SEGMENT 70
9.3 DIAGNOSTIC LABORATORIES 71
9.3.1 LARGE NUMBER OF DIAGNOSTIC LABORATORIES CARRYING OUT TESTS GLOBALLY TO DRIVE MARKET GROWTH 71

9.4 HOME CARE SETTINGS 72
9.4.1 WIDESPREAD USE OF PREGNANCY KITS IN HOME CARE SETTINGS TO DRIVE MARKET GROWTH 72
9.5 RESEARCH LABORATORIES & INSTITUTES 73
9.5.1 RESEARCH IN DEVELOPING NEW URINALYSIS KITS FOR DISEASE DIAGNOSIS WILL DRIVE MARKET GROWTH 73
10 URINALYSIS MARKET, BY REGION 74
10.1 INTRODUCTION 75
10.2 NORTH AMERICA 76
10.2.1 US 80
10.2.1.1 US dominates the North American urinalysis market 80
10.2.2 CANADA 82
10.2.2.1 Increasing awareness about UTIs will drive market growth in Canada 82
10.3 EUROPE 84
10.3.1 GERMANY 87
10.3.1.1 Germany dominates the European urinalysis market 87
10.3.2 UK 89
10.3.2.1 UK to register the highest growth in the European market during the forecast period 89
10.3.3 FRANCE 90
10.3.3.1 Favorable demographics will support the adoption of urinalysis equipment in France 90
10.3.4 ITALY 92
10.3.4.1 Large geriatric population to drive the growth of the urinalysis market in Italy 92
10.3.5 SPAIN 94
10.3.5.1 Prevalence of CKD in Spain to drive the demand for urinalysis 94
10.3.6 REST OF EUROPE 95
10.4 ASIA PACIFIC 97
10.4.1 CHINA 101
10.4.1.1 China accounts for the largest share of the APAC market 101
10.4.2 JAPAN 103
10.4.2.1 Well-developed healthcare system and universal healthcare reimbursement policy will ensure steady market growth 103
10.4.3 INDIA 104
10.4.3.1 Increasing incidence of CKD is driving market growth 104
10.4.4 REST OF APAC 106
10.5 REST OF THE WORLD 108

11 COMPETITIVE LANDSCAPE 111
11.1 OVERVIEW 111
11.2 MARKET RANKING ANALYSIS, 2018 111
11.3 KEY STRATEGIES 114
11.3.1 PRODUCT LAUNCHES, 2016–2018 114
11.3.2 EXPANSIONS, 2016–2018 114
11.3.3 PARTNERSHIPS, 2016–2018 114
11.4 COMPETITIVE LEADERSHIP MAPPING (2018) 115
11.4.1 VENDOR INCLUSION CRITERIA 115
11.4.2 VISIONARY LEADERS 115
11.4.3 INNOVATORS 115
11.4.4 DYNAMIC DIFFERENTIATORS 115
11.4.5 EMERGING COMPANIES 115
11.5 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2018) 116
11.5.1 PROGRESSIVE COMPANIES 116
11.5.2 STARTING BLOCKS 117
11.5.3 RESPONSIVE COMPANIES 117
11.5.4 DYNAMIC COMPANIES 117
12 COMPANY PROFILES 118
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 CARDINAL HEALTH, INC. 118
12.2 ALERE, INC. (A PART OF ABBOTT LABORATORIES) 120
12.3 SIEMENS HEALTHINEERS 122
12.4 ROCHE DIAGNOSTICS 124
12.5 BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORPORATION) 126
12.6 SYSMEX CORPORATION 128
12.7 QUIDEL CORPORATION 130
12.8 BIO-RAD LABORATORIES, INC. 132
12.9 ARKRAY, INC. 134
12.10 ACON LABORATORIES, INC. 135
12.11 77 ELEKTRONIKA KFT 137
12.12 URIT MEDICAL ELECTRONIC GROUP CO., LTD. 138
12.13 DIRUI INDUSTRIAL CO., LTD. 139

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

13 APPENDIX 140
13.1 INSIGHTS OF INDUSTRY EXPERTS 140
13.2 DISCUSSION GUIDE 141
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 143
13.4 AVAILABLE CUSTOMIZATIONS 145
13.5 RELATED REPORTS 145
13.6 AUTHOR DETAILS 146

LIST OF TABLES

TABLE 1 URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 40
TABLE 2 URINALYSIS CONSUMABLES MARKET, BY REGION, 2017–2024 (USD MILLION) 41
TABLE 3 URINALYSIS CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION) 41
TABLE 4 URINALYSIS PREGNANCY & FERTILITY KITS MARKET, BY REGION,
2017–2024 (USD MILLION) 42
TABLE 5 URINALYSIS DIPSTICKS MARKET, BY REGION, 2017–2024 (USD MILLION) 43
TABLE 6 URINALYSIS DISPOSABLES MARKET, BY REGION, 2017–2024 (USD MILLION) 44
TABLE 7 URINALYSIS REAGENTS MARKET, BY REGION, 2017–2024 (USD MILLION) 45
TABLE 8 URINALYSIS INSTRUMENTS MARKET, BY REGION, 2017–2024 (USD MILLION) 45
TABLE 9 URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 46
TABLE 10 AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 46
TABLE 11 AUTOMATED URINE ANALYZERS MARKET, BY REGION, 2017–2024 (USD MILLION) 47
TABLE 12 AUTOMATED BIOCHEMICAL URINE ANALYZERS MARKET, BY REGION,
2017–2024 (USD MILLION) 47
TABLE 13 AUTOMATED SEDIMENT URINE ANALYZERS MARKET, BY TYPE,
2017–2024 (USD MILLION) 48
TABLE 14 SEDIMENT URINE ANALYZERS MARKET, BY REGION, 2017–2024 (USD MILLION) 48
TABLE 15 AUTOMATED MICROSCOPY ANALYZERS MARKET, BY REGION,
2017–2024 (USD MILLION) 49
TABLE 16 FLOW CYTOMETRY ANALYZERS MARKET, BY REGION, 2017–2024 (USD MILLION) 50
TABLE 17 INTEGRATED URINE ANALYZERS MARKET, BY REGION, 2017–2024 (USD MILLION) 50
TABLE 18 SEMI-AUTOMATED URINE ANALYZERS MARKET, BY REGION,
2017–2024 (USD MILLION) 51
TABLE 19 POINT-OF-CARE URINE ANALYZERS MARKET, BY REGION,
2017–2024 (USD MILLION) 52
TABLE 20 URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION) 54
TABLE 21 PREGNANCY & FERTILITY TESTS MARKET, BY REGION, 2017–2024 (USD MILLION) 55
TABLE 22 BIOCHEMICAL URINALYSIS MARKET, BY TYPE, 2017–2024 (USD MILLION) 56
TABLE 23 BIOCHEMICAL URINALYSIS MARKET, BY REGION, 2017–2024 (USD MILLION) 56
TABLE 24 BIOCHEMICAL URINALYSIS MARKET FOR LABORATORY TESTS, BY REGION,
2017–2024 (USD MILLION) 57
TABLE 25 BIOCHEMICAL URINALYSIS MARKET FOR POC TESTS, BY REGION,
2017–2024 (USD MILLION) 57
TABLE 26 SEDIMENT URINALYSIS MARKET, BY REGION, 2017–2024 (USD MILLION) 58
TABLE 27 URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 60
TABLE 28 URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE,
2017–2024 (USD MILLION) 61
TABLE 29 URINALYSIS MARKET FOR DISEASE SCREENING, BY REGION,
2017–2024 (USD MILLION) 61
TABLE 30 URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY REGION,
2017–2024 (USD MILLION) 62
TABLE 31 URINALYSIS MARKET FOR KIDNEY DISEASES, BY REGION,
2017–2024 (USD MILLION) 63
TABLE 32 URINALYSIS MARKET FOR DIABETES, BY REGION, 2016–2023 (USD MILLION) 63
TABLE 33 URINALYSIS MARKET FOR LIVER DISEASES, BY REGION,
2017–2024 (USD MILLION) 64
TABLE 34 URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS,
BY REGION, 2017–2024 (USD MILLION) 65
TABLE 35 URINALYSIS MARKET FOR PREGNANCY & FERTILITY, BY REGION,
2017–2024 (USD MILLION) 66
TABLE 36 URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION) 68
TABLE 37 URINALYSIS END-USER MARKET, BY PRODUCT, 2018 (USD MILLION) 69
TABLE 38 URINALYSIS END-USER MARKET, BY APPLICATION, 2018 (USD MILLION) 69
TABLE 39 URINALYSIS END-USER MARKET, BY TEST TYPE, 2018 (USD MILLION) 69
TABLE 40 URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY REGION,
2017–2024 (USD MILLION) 70
TABLE 41 URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION,
2017–2024 (USD MILLION) 71
TABLE 42 URINALYSIS MARKET FOR HOME CARE SETTINGS, BY REGION,
2017–2024 (USD MILLION) 72
TABLE 43 URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES,
BY REGION, 2017–2024 (USD MILLION) 73
TABLE 44 URINALYSIS MARKET, BY REGION, 2017–2024 (USD MILLION) 75
TABLE 45 NORTH AMERICA: URINALYSIS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 77
TABLE 46 NORTH AMERICA: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 77
TABLE 47 NORTH AMERICA: URINALYSIS MARKET, BY TEST TYPE,
2017–2024 (USD MILLION) 77
TABLE 48 NORTH AMERICA: URINALYSIS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 78
TABLE 49 NORTH AMERICA: URINALYSIS MARKET, BY END USER,
2017–2024 (USD MILLION) 78
TABLE 50 NORTH AMERICA: URINALYSIS END-USER MARKET, BY PRODUCT,
2018 (USD MILLION) 79
TABLE 51 NORTH AMERICA: URINALYSIS END-USER MARKET, BY APPLICATION,
2018 (USD MILLION) 79
TABLE 52 US: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 81
TABLE 53 US: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION) 81
TABLE 54 US: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 81
TABLE 55 US: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION) 82
TABLE 56 CANADA: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 82
TABLE 57 CANADA: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION) 83
TABLE 58 CANADA: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 83
TABLE 59 CANADA: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION) 83
TABLE 60 EUROPE: URINALYSIS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 84
TABLE 61 EUROPE: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 84
TABLE 62 EUROPE: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION) 85
TABLE 63 EUROPE: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 85
TABLE 64 EUROPE: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION) 85
TABLE 65 EUROPE: URINALYSIS END USER MARKET, BY PRODUCT, 2018 (USD MILLION) 86
TABLE 66 EUROPE: URINALYSIS END USER MARKET, BY APPLICATION, 2018 (USD MILLION) 86
TABLE 67 GERMANY: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 87
TABLE 68 GERMANY: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION) 87
TABLE 69 GERMANY: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 88
TABLE 70 GERMANY: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION) 88
TABLE 71 UK: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 89
TABLE 72 UK: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION) 89
TABLE 73 UK: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 90
TABLE 74 UK: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION) 90
TABLE 75 FRANCE: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 91
TABLE 76 FRANCE: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION) 91
TABLE 77 FRANCE: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 91
TABLE 78 FRANCE: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION) 92
TABLE 79 ITALY: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 92
TABLE 80 ITALY: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION) 93
TABLE 81 ITALY: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 93
TABLE 82 ITALY: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION) 93
TABLE 83 SPAIN: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 94
TABLE 84 SPAIN: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION) 94
TABLE 85 SPAIN: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 95
TABLE 86 SPAIN: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION) 95
TABLE 87 ROE: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 96
TABLE 88 ROE: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION) 96
TABLE 89 ROE: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 96
TABLE 90 ROE: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION) 97
TABLE 91 APAC: URINALYSIS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 99
TABLE 92 APAC: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 99
TABLE 93 APAC: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION) 99
TABLE 94 APAC: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 100
TABLE 95 APAC: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION) 100
TABLE 96 APAC: URINALYSIS END USER MARKET, BY PRODUCT, 2018 (USD MILLION) 100
TABLE 97 APAC: URINALYSIS END USER MARKET, BY APPLICATION, 2018 (USD MILLION) 101
TABLE 98 CHINA: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 101
TABLE 99 CHINA: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION) 102
TABLE 100 CHINA: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 102
TABLE 101 CHINA: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION) 102
TABLE 102 JAPAN: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 103
TABLE 103 JAPAN: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION) 103
TABLE 104 JAPAN: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 104
TABLE 105 JAPAN: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION) 104
TABLE 106 INDIA: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 105
TABLE 107 INDIA: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION) 105
TABLE 108 INDIA: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 105
TABLE 109 INDIA: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION) 106
TABLE 110 ROAPAC: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 106
TABLE 111 ROAPAC: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION) 106
TABLE 112 ROAPAC: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 107
TABLE 113 ROAPAC: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION) 107
TABLE 114 ROW: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 108
TABLE 115 ROW: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION) 108
TABLE 116 ROW: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 109
TABLE 117 ROW: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION) 109
TABLE 118 ROW: URINALYSIS END USER MARKET, BY PRODUCT, 2018 (USD MILLION) 109
TABLE 119 ROW: URINALYSIS END USER MARKET BY APPLICATION, 2018 (USD MILLION) 110


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 20
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 22
FIGURE 3 URINALYSIS MARKET: BOTTOM-UP APPROACH 24
FIGURE 4 URINALYSIS MARKET: TOP-DOWN APPROACH 25
FIGURE 5 DATA TRIANGULATION METHODOLOGY 26
FIGURE 6 URINALYSIS MARKET, BY PRODUCT, 2019 VS. 2024 (USD MILLION) 28
FIGURE 7 URINALYSIS MARKET, BY TEST TYPE, 2019 VS. 2024 (USD MILLION) 29
FIGURE 8 URINALYSIS MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION) 29
FIGURE 9 URINALYSIS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION) 30
FIGURE 10 URINALYSIS MARKET, BY REGION, 2019 VS. 2024 (USD MILLION) 30
FIGURE 11 RISING GLOBAL INCIDENCE OF UTIS AND KIDNEY DISEASES TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 32
FIGURE 12 CONSUMABLES DOMINATED THE NORTH AMERICAN URINALYSIS MARKET IN 2019 33
FIGURE 13 COUNTRIES IN ASIA TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD 34
FIGURE 14 URINALYSIS MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES 35
FIGURE 15 GROWING AGING POPULATION, BY REGION, 2015 VS. 2030 36
FIGURE 16 CONSUMABLES SEGMENT TO WITNESS HIGHER GROWTH DURING THE FORECAST PERIOD 40
FIGURE 17 PREGNANCY & FERTILITY TESTS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2018 54
FIGURE 18 DISEASE SCREENING APPLICATIONS TO DOMINATE THE URINALYSIS MARKET DURING THE FORECAST PERIOD 60
FIGURE 19 HOSPITALS & CLINICS TO DOMINATE THE URINALYSIS MARKET DURING THE FORECAST PERIOD 68
FIGURE 20 APAC TO WITNESS THE HIGHEST GROWTH IN THE URINALYSIS MARKET DURING THE FORECAST PERIOD 75
FIGURE 21 NORTH AMERICA: URINALYSIS MARKET SNAPSHOT 76
FIGURE 22 POPULATION GROWTH IN THE US, 2016–2060 80
FIGURE 23 APAC: URINALYSIS MARKET SNAPSHOT 98
FIGURE 24 KEY DEVELOPMENTS IN THE URINALYSIS MARKET FROM 2016 TO 2019 111
FIGURE 25 BIOCHEMICAL URINALYSIS 111
FIGURE 26 SEDIMENT URINALYSIS 112
FIGURE 27 PREGNANCY AND FERTILITY TESTS 113
FIGURE 28 MNM DIVE-VENDOR COMPARISON MATRIX: URINALYSIS MARKET 116
FIGURE 29 MNM DIVE-VENDOR COMPARISON MATRIX FOR START-UPS: URINALYSIS MARKET 117
FIGURE 30 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT 118
FIGURE 31 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2017) 120
FIGURE 32 SIEMENS AG: COMPANY SNAPSHOT 122
FIGURE 33 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT 124

FIGURE 34 DANAHER CORPORATION: COMPANY SNAPSHOT 126
FIGURE 35 SYSMEX CORPORATION: COMPANY SNAPSHOT 128
FIGURE 36 QUIDEL CORPORATION: COMPANY SNAPSHOT 130
FIGURE 37 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT 132


★調査レポート[尿検査の世界市場予測(~2024年)] ( Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, PoC Analyzers), Application (UTI, Diabetes, Pregnancy), End User (Hospital, Labs, Homecare) & Test Type - Global Forecast to 2024 / MD-3259) 販売に関する免責事項
[尿検査の世界市場予測(~2024年)] ( Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, PoC Analyzers), Application (UTI, Diabetes, Pregnancy), End User (Hospital, Labs, Homecare) & Test Type - Global Forecast to 2024 / MD-3259) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆